STRATA Skin Sciences, Inc. to Report Fiscal 2017 Financial Results on Thursday, March 29

-- Conference Call to Follow at 4:30 p.m. EDT --

HORSHAM, Pa., March 27, 2018 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, will release fiscal 2017 financial results on Thursday, March 29, after the market close.  STRATA Skin Sciences’ President and Chief Executive Officer, Frank J. McCaney, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress.

Conference Call Details:
Date:                            Thursday, March 29
Time:                            4:30 pm Eastern Time
Toll Free:                      888-394-8218
International:                323-794-2149
Passcode:                     6380302
Webcast:                      www.strataskinsciences.com

About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market.  Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation; and NORDLYS, a multi-technology aesthetic laser device.

Investor Contacts:
Frank McCaney, Chief Executive Officer
STRATA Skin Sciences, Inc.
215-619-3200
[email protected]

Bob Yedid, Managing Director
LifeSci Advisors, LLC
646-597-6989
[email protected]